Does GOLIMUMAB Cause Nephrolithiasis? 534 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 534 reports of Nephrolithiasis have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.8% of all adverse event reports for GOLIMUMAB.
534
Reports of Nephrolithiasis with GOLIMUMAB
0.8%
of all GOLIMUMAB reports
3
Deaths
342
Hospitalizations
How Dangerous Is Nephrolithiasis From GOLIMUMAB?
Of the 534 reports, 3 (0.6%) resulted in death, 342 (64.0%) required hospitalization, and 2 (0.4%) were considered life-threatening.
Is Nephrolithiasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 534 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Nephrolithiasis?
ADALIMUMAB (2,416)
ETANERCEPT (1,292)
INFLIXIMAB (981)
METHOTREXATE (979)
ABATACEPT (788)
TOPIRAMATE (768)
CERTOLIZUMAB PEGOL (735)
RITUXIMAB (709)
TOFACITINIB (699)
SODIUM OXYBATE (698)
Which GOLIMUMAB Alternatives Have Lower Nephrolithiasis Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN